TELA Bio (TELA) Consolidated Net Income (2018 - 2026)

TELA Bio's Consolidated Net Income history runs 9 years deep, the most recent figure standing at -$12.3 million for Q1 2026.

• On a quarterly basis, Consolidated Net Income fell 8.96% year-over-year to -$12.3 million in Q1 2026; TTM through Mar 2026 was -$39.7 million, a 695.83% decrease from a year earlier, with the FY2025 full-year figure at -$38.7 million, down 550.27% from the prior year.
• Consolidated Net Income slipped to -$12.3 million in Q1 2026 per TELA's latest filing, from -$8.9 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $29.2 million in Q4 2024 and bottomed at -$13.0 million in Q4 2023.
• The 5-year median for Consolidated Net Income is -$11.2 million (2022), against an average of -$8.4 million.
• Across the five-year window, Consolidated Net Income soared 324.95% in 2024 and sank 130.42% in 2025, its largest moves.
• Year by year, Consolidated Net Income stood at -$9.7 million in 2022, then tumbled by 34.47% to -$13.0 million in 2023, then soared by 324.95% to $29.2 million in 2024, then sank by 130.42% to -$8.9 million in 2025, then slumped by 37.95% to -$12.3 million in 2026.
• Per Business Quant, the three latest TELA Consolidated Net Income figures stand at -$12.3 million (Q1 2026), -$8.9 million (Q4 2025), and -$8.6 million (Q3 2025).